Close
At BiomeSense, we believe the gut microbiome is poised to join genomics as a powerful avenue of personalized medicine, with the potential of transforming the lives of millions worldwide.
To accelerate our path to that future, we developed the first AI-enabled technology platform for reliable, longitudinal, and low-cost generation & analysis of microbiome data. Our mission is to partner with leading scientists and companies across the field, providing them with continuous, comprehensive microbiome data and AI-enabled bioinformatics to unlock the microbiome’s full personalized medicine potential.
Today, microbiome datasets are often limited because of the high cost and difficulty of generating & analyzing data.
As a result, we often can't even observe most host-microbiome interactions - much less leverage them for personalized medicine.
BiomeSense's GutLab technology enables continuous tracking of the patient's gut microbiome throughout the treatment journey.
These samples are sequenced by BiomeSense & matched to clinical data to create a high-resolution map of the microbiome, revealing extensive natural variation and treatment effects.
MetaBiome transforms & analyzes the data using both well-established and novel time-series analyses, enabling identification of clinically-relevant shifts and other patterns meriting further investigation.
By combining high-resolution data & AI, BiomeSense's platform unlocks an entire dimension of previously inaccessible host-microbiome interactions, such as a potentially novel signature suggesting the gut microbiome may be a biomarker for active tumor burden.
Our platform combines novel hardware with AI-enabled bioinformatics to unlock the personalized medicine potential of the gut microbiome.
We’re partnering with leading scientists, institutions, and companies conducting clinical research into the gut microbiome, with a focus on personalized biomarker discovery and novel product development.
By leveraging our technology, our partners receive continuous, comprehensive microbiome data generation and AI-enabled bioinformatics for unprecedented insight into the microbiome’s role in health and disease.
Our leadership team is focused on unlocking the vast potential of the human gut microbiome by building unique technologies
that will disrupt the industry.
